| Dec'19 | Dec'18 | Dec'17 | ||||
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net loss | ||||||
-7,117 | -13,791 | -5,071 | ||||
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||||||
Depreciation and amortization expense | ||||||
2,186 | 1,341 | 1,360 | ||||
Loss on disposal of property and equipment | ||||||
-98 | - | - | ||||
Stock-based compensation expense | ||||||
12,721 | 7,121 | 1,860 | ||||
Noncash interest expense | ||||||
- | 14 | 20 | ||||
Provision for bad debt | ||||||
478 | - | - | ||||
Deferred rent | ||||||
135 | -337 | -528 | ||||
Changes in operating assets and liabilities: | ||||||
Accounts receivable | ||||||
15,232 | 2,766 | 2,478 | ||||
Prepaid expenses and other current assets | ||||||
5,609 | 863 | 8 | ||||
Other assets | ||||||
1 | - | 75 | ||||
Accounts payable | ||||||
6,837 | 4,932 | 1,552 | ||||
Accrued expenses and other current liabilities | ||||||
10,126 | 1,324 | 469 | ||||
Deferred revenue | ||||||
61 | 454 | - | ||||
Deferred revenue | ||||||
- | - | 171 | ||||
Net cash provided by (used in) operating activities | ||||||
4,413 | -1,897 | -1,672 | ||||
Cash flows from investing activities: | ||||||
Acquisition of property and equipment, including costs capitalized for development of internal-use software | ||||||
2,975 | 3,668 | 1,185 | ||||
Net cash used in investing activities | ||||||
-2,975 | -3,668 | -1,185 | ||||
Cash flows from financing activities: | ||||||
Proceeds from initial public offering, net of underwriting discounts and commissions | ||||||
- | 52,313 | - | ||||
Proceeds from exercise of stock options | ||||||
2,982 | 861 | 1,549 | ||||
Repurchase of common stock | ||||||
- | - | 9,229 | ||||
Proceeds from borrowings on line of credit | ||||||
- | 22,729 | 20,300 | ||||
Repayments of borrowings on line of credit | ||||||
- | 24,729 | 18,300 | ||||
Repayments of term loan | ||||||
- | 2,625 | 1,500 | ||||
Payments of initial public offering costs | ||||||
- | 3,713 | - | ||||
Net cash provided by financing activities | ||||||
2,982 | 44,836 | -7,180 | ||||
Net increase (decrease) in cash, cash equivalents and restricted cash | ||||||
4,420 | 39,271 | -10,037 | ||||
Supplemental disclosure of cash flow information | ||||||
Cash paid for interest | ||||||
- | 214 | 352 | ||||
Supplemental disclosure of noncash investing and financing information: | ||||||
Conversion of convertible preferred stock to common stock | ||||||
- | 88,352 | 98 | ||||
Conversion of Series B redeemable convertible preferred stock to Series B-1 redeemable convertible preferred stock | ||||||
- | - | 7,900 | ||||
Retirement of treasury stock | ||||||
- | - | 9,229 | ||||
Accretion of redeemable convertible preferred stock to redemption value | ||||||
- | 37,415 | 14,093 | ||||